Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Gene transfer of COX-1 proves to restore PGI2 synthesis

Sep. 10, 2001

Orally active NO-independent sGC stimulators from Bayer with vasodilating and hypotensive activity

Sep. 10, 2001

Jomed and Oxigene form collaboration on restenosis inhibitors

Sep. 10, 2001

Endothelin receptor antagonists identified by Actelion team

Sep. 10, 2001

ADIR patents novel treatments for endothelial dysfunction

Sep. 10, 2001

Potential of darusentan in CHF, hypertension supported by clinical trial results

Sep. 7, 2001

Pharmacyclics reports interim phase I results for Antrin photoangioplasty for CAD

Sep. 7, 2001

Important new information on heart failure now available from Prous Science

Sep. 7, 2001

Long-term outcome in patients with severe PH receiving continuous s.c. UT-15

Sep. 7, 2001

Vasogen receives clearance to begin pivotal clinical trial of PAD treatment

Sep. 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...